Clinical Trial Update: Pharmacogenetic Study of Mirtazapine Response in Depressed Patients [NA]

View source ↗

Summary

An update on a pharmacogenetic study evaluating genetic factors that influence response to mirtazapine in patients with depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Mirtazapine (Remeron) (mirtazapine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Depression | NA | Status: UNKNOWN